SB 2933: DOH; INSURANCE COMMISSIONER; HEALTH CARE; COSTS; PRESCRIPTION DRUG AFFORDABILITY BOARD; UPPER PAYMENT LIMITS; OUT-OF-POCKET MAXIMUMS; COPAYMENT ADJUSTMENT PROGRAMS; REPORTS; RULES; APPROPRIATION
- Session Year: 2025-2026
- House: Senate
- Latest Version Date: 2026-01-23
Current Status:
Failed
(2026-02-18: The committee on CPN deferred the measure.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Final Decking
Enacted
Establishes the Prescription Drug Affordability Board within the Department of Health to conduct affordability reviews on high-cost prescription drugs and establish upper payment limits under certain circumstances. Establishes out-of-pocket maximums for prescribed insulin, asthma inhalers, and epinephrine auto-injectors. Prohibits copayment adjustment programs. Requires health insurers, mutual benefit societies, and health maintenance organizations to comply with certain affordability measures. Requires annual reports to the Legislature. Requires adoption of rules by the Affordability Board and Insurance Commissioner. Appropriates funds.
Discussed in Hearing
1MINSenate Standing Committee on Commerce and Consumer Protection
1MINSenate Standing Committee on Health and Human Services
1MINSenate Standing Committee on Economic Development and Tourism
1MINSenate Standing Committee on Transportation
5MINSenate Standing Committee on Commerce and Consumer Protection
5MINSenate Standing Committee on Health and Human Services
5MIN